Reliability-centered computational toxicity screening for early small-molecule discovery.
ToxVerity currently provides endpoint-specific predictions for Ames mutagenicity, hERG blockade, SR-ARE, SR-ATAD5, SR-MMP and SR-p53.
Bacterial mutagenicity-related activity for early genotoxicity screening.
Potential cardiac hERG potassium-channel blockade.
Oxidative-stress response through the antioxidant response element.
DNA-damage-associated stress response.
Mitochondrial membrane-potential disruption.
p53 stress-response pathway activation.
ToxVerity is designed to report not only what the model predicts, but how much support exists for that prediction.
Probability after calibration.
Endpoint-specific decision threshold.
Ensemble disagreement.
Representation by development chemistry.
Similarity to training chemistry.
Novel structural scaffold detection.
Distribution-shift warning.
No supported binary call when evidence is insufficient.
SMILES or molecular library.
Reproducible structure processing.
Endpoint-specific inference.
Probability interpretation.
Domain, novelty and uncertainty.
Experimental follow-up recommendation.
The production customer platform is not yet publicly open. Access is currently arranged for research pilots and evaluation engagements.